Hisamitsu Pharmaceutical Co Inc 4530
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 3,738.00
- Day Range
- JPY 3,700.00–3,767.00
- 52-Week Range
- JPY 3,541.00–5,497.00
- Bid/Ask
- JPY 3,743.00 / JPY 3,750.00
- Market Cap
- JPY 274.71 Bil
- Volume/Avg
- 179,900 / 156,570
Key Statistics
- Price/Earnings (Normalized)
- 20.73
- Price/Sales
- 2.03
- Dividend Yield (Trailing)
- 2.27%
- Dividend Yield (Forward)
- 2.30%
- Total Yield
- 5.84%
Company Profile
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,682
- Website
- http://www.hisamitsu.co.jp
Comparables
Valuation
|
Metric
|
4530
|
600380
|
4581
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.73 | 16.74 | 27.83 |
Price/Book Value | 1.07 | 1.63 | 0.84 |
Price/Sales | 2.03 | 1.43 | 2.17 |
Price/Cash Flow | 14.85 | 5.05 | 14.48 |
Price/Earnings
4530
600380
4581
Financial Strength
|
Metric
|
4530
|
600380
|
4581
|
|---|---|---|---|
Quick Ratio | 3.67 | 2.03 | 4.20 |
Current Ratio | 4.22 | 2.38 | 5.16 |
Interest Coverage | 924.44 | 21.41 | 68.75 |
Quick Ratio
4530
600380
4581
Profitability
|
Metric
|
4530
|
600380
|
4581
|
|---|---|---|---|
Return on Assets (Normalized) | 5.98% | 3.74% | 2.57% |
Return on Equity (Normalized) | 7.43% | 9.97% | 3.09% |
Return on Invested Capital (Normalized) | 6.30% | 3.77% | 2.64% |
Return on Assets
4530
600380
4581
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Dpxscdlkqh | Hwcngtr | $80.3 Bil | |||
| Zoetis Inc Class A
ZTS
| Tvgvhztdb | Dghx | $77.8 Bil | |||
| Haleon PLC ADR
HLN
| Gytpbvjlr | Crl | $37.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Xmgzqvrm | Jpwq | $12.1 Bil | |||
| Viatris Inc
VTRS
| Mmslhylq | Kfgw | $12.1 Bil | |||
| Catalent Inc
CTLT
| Psbmfnqw | Tvkkndq | $10.0 Bil | |||
| Perrigo Co PLC
PRGO
| Cgknwxx | Bzmp | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Qxjgpwg | Vjgbgq | $3.2 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Pgrndwyj | Rmny | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Qxpcmbwqm | Zrg | $2.7 Bil |